SULFABID Drug Patent Profile
Which patents cover Sulfabid, and what generic alternatives are available?
Sulfabid is a drug marketed by Pharm Res Assoc and Purdue Frederick and is included in two NDAs.
The generic ingredient in SULFABID is sulfaphenazole. There is one drug master file entry for this compound. Additional details are available on the sulfaphenazole profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SULFABID?
- What are the global sales for SULFABID?
- What is Average Wholesale Price for SULFABID?
Summary for SULFABID
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 103 |
| Patent Applications: | 1,969 |
| DailyMed Link: | SULFABID at DailyMed |
US Patents and Regulatory Information for SULFABID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharm Res Assoc | SULFABID | sulfaphenazole | SUSPENSION;ORAL | 013093-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Purdue Frederick | SULFABID | sulfaphenazole | TABLET;ORAL | 013092-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
